Enova International saw its IBD SmartSelect Composite Rating rise to 96 Wednesday, up from 94 the day before.
The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.
Enova International is not currently near a proper buy zone. See if the stock goes on to form a new chart pattern and offer a new buying opportunity.
Looking For The Best Stocks To Buy And Watch? Start Here
The stock sports a 93 EPS Rating, which means its recent quarterly and annual earnings growth tops 93% of all stocks.
Its Accumulation/Distribution Rating of E shows aggressive selling by institutional investors over the last 13 weeks. Look for the rating to improve to at least a C or better.
The company posted a 43% earnings gain for Q4. Top line growth was flat, matching the prior report's 25%.
Enova International holds the No. 1 rank among its peers in the Finance-Consumer Loans industry group. Ezcorp Cl A and Mr. Cooper Group are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
